Endorsed by SAPA-GP, Organizing Committee of 4th Annual Precision Medicine and Immuno-Oncology China Summit (PMIO 2021) is delighted to invite you to Shanghai, China on September 27-28, 2021. PMIO 2021 takes an opportunity to honor top researchers for delivering innovative solutions and technologies. The theme of the conference “Latest Innovations in Precision Medicine and Immuno-Oncology in China” is designed in order to improve the understanding, investigation, prevention and treatment of many diseases.
PMIO 2021 aims to explore the outlook and development of Personalized medicine, Biomarkers, Pharmacogenomics, Precision Immunotherapy and Gene Editing in China, which can inform future targets for industry, policy makers, and other stakeholders.
Snapshots of PMIO China 2021
- Frontiers of COVID-19 vaccine development
- Cell therapy industrialization and commercialization strategies
- Cell and Gene therapy process development, quality control and GMP manufacturing
- Multi-marker and immuno-oncology companion diagnostics
- Genomics, big data and the next generation of targeted therapies
- Small-Molecule Immuno-Oncology Therapy: Advances, Challenges and New Directions
- Pharmacogenomics and its role in precision medicine
- Assay Development for Emerging Single-Cell Platforms
- Best practices in partnering with CROs for successful Companion Diagnostic development
- Nanobody Engineering: Toward next generation immunotherapies
PMIO China 2020 Review
Precision Medicine and Immuno-oncology China Summit 2021 (PMIO 2021) Organizing Committee
For speaking opportunities, sponsorship, delegate registration and all other general enquiries, please contact us by
Tel: +86 15002180039
Email: enquriy@gecgroup.com.cn